IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,481,688 | +142.6% | 282,400 | +188.5% | 0.01% | +150.0% |
Q2 2023 | $1,847,373 | +5498.1% | 97,900 | +618.1% | 0.00% | – |
Q3 2019 | $33,000 | +10.0% | 13,633 | 0.0% | 0.00% | – |
Q2 2019 | $30,000 | -81.5% | 13,633 | -77.3% | 0.00% | – |
Q1 2019 | $162,000 | -47.1% | 59,951 | -6.1% | 0.00% | -100.0% |
Q4 2018 | $306,000 | -49.3% | 63,833 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $604,000 | -14.2% | 63,833 | -11.8% | 0.00% | 0.0% |
Q2 2018 | $704,000 | +20.3% | 72,333 | +30.1% | 0.00% | 0.0% |
Q1 2018 | $585,000 | +87.5% | 55,600 | +14.2% | 0.00% | – |
Q4 2017 | $312,000 | +9.1% | 48,700 | +30.2% | 0.00% | – |
Q3 2017 | $286,000 | – | 37,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
Northeast Financial Consultants Inc | 34,315 | $133,000 | 0.06% |